Do you want to read an article? Please log in or register.
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
Interstitial Lung DiseasePulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Tomassetti S, Ravaglia C, Wells AU, Cavazza A, Colby TV, Rossi G, Ley B, Ryu JH, Puglisi S, Arcadu A, Marchi M, Sultani F, Martinello S, Donati L, Gurioli C, Gurioli C, Tantalocco P, Hetzel J, Dubini A, Piciucchi S, Klersy C, Lavorini F, Poletti V
doi: 10.1016/S2213-2600(20)30122-3.
RECOMMENDED
Interstitial Lung Disease
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A, RELIEF investigators.
doi: 10.1016/S2213-2600(20)30554-3
Pulmonary Fibrosis
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
Lancet Respir Med.
Johannson KA, Strâmbu I, Ravaglia C, Grutters JC, Valenzuela C, Mogulkoc N, Luppi F, Richeldi L, Wells AU, Vancheri C, Kreuter M; Erice ILD Working Group
doi: 10.1016/
RECOMMENDED
Pulmonary Fibrosis
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir Rev.
Khor YH, Ng Y, Barnes H, Goh NSL, McDonald CF, Holland AE
doi: 10.1183/16000617.0158-2019.
Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre
Swiss Med Wkly.
Guler S, Zumstein P, Berezowska S, Pöllinger A, Geiser T, Funke-Chambour M
doi: 10.4414/smw.2018.14577.
RECOMMENDED
Pulmonary Fibrosis
Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres
Am J Respir Crit Care Med.
Popescu I, Mannem H, Winters SA, Hoji A, Silveira F, McNally E, Pipeling MR, Lendermon EA, Morrell MR, Pilewski JM, Hanumanthu VS, Zhang Y, Gulati S, Shah PD, Iasella CJ, Ensor CR, Armanios M, McDyer JF
doi: 10.1164/rccm.
RECOMMENDED
Pulmonary Fibrosis
Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Duckworth A, Gibbons MA, Allen RJ, Almond H, Beaumont RN, Wood AR, Lunnon K, Lindsay MA, Wain LV, Tyrrell J, Scotton CJ
doi: 10.1016/S2213-2600(20)30364-7.Visit the original publication at ncbi.nlm.nih.gov
Pulmonary Fibrosis
Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis
Respirology.
Nyilas S, Schreder T, Singer F, Poellinger A, Geiser TK, Latzin P, Funke M
doi: 10.1111/resp.13294.
RECOMMENDED
EmphysemaPulmonary FibrosisLung CancerPulmonary Hypertension
Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Luppi F, Kalluri M, Faverio P, Kreuter M, Ferrara G
doi: 10.1186/s12931-021-01711-1